A proof-of-concept study of SB-751689 [ronacaleret] in men and post-menopausal women with a fractured distal radius.
Phase of Trial: Phase II
Latest Information Update: 18 Apr 2017
At a glance
- Drugs Ronacaleret (Primary)
- Indications Fracture
- Focus Proof of concept; Therapeutic Use
- Sponsors GlaxoSmithKline
- 14 Apr 2010 Additional trial location [China] identified as reported by ClinicalTrials.gov.
- 11 Sep 2009 Results presented at the 31st Annual Meeting of the American Society for Bone and Mineral Research.
- 18 Dec 2008 Actual end date (Jan 2009) added as reported by ClinicalTrials.gov.